Sonodynamical reversion of immunosuppressive microenvironment in prostate cancer via engineered exosomes

References

• Alam MM, Yang D, Trivett A, et al. (2018). HMGN1 and R848 synergistically activate dendritic cells using multiple signaling pathways. Front Immunol 9:2982.
   PubMed Web of Science ®Google Scholar
• Antonarakis ES, Piulats JM, Gross-Goupil M, et al. (2020). Pembrolizumab for treatment-refractory metastatic castration-resistant prostate cancer: multicohort, open-label phase II KEYNOTE-199 study. J Clin Oncol 38:395–405.
   PubMed Web of Science ®Google Scholar
• Bansal D, Reimers MA, Knoche EM, et al. (2021). Immunotherapy and immunotherapy combinations in metastatic castration-resistant prostate cancer. Cancers 13:334.
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kim MS. (2015). Using exosomes, naturally-equipped nanocarriers, for drug delivery. J Control Release 219:396–405.
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Du W, et al. (2019). Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci 26:78.
   PubMed Web of Science ®Google Scholar
• Elsharkasy OM, Nordin JZ, Hagey DW, et al. (2020). Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev 159:332–43.
   PubMed Web of Science ®Google Scholar
• Grassi F, Tell G, Robbie-Ryan M, et al. (2007). Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci U S A 104:15087–92.
   PubMed Web of Science ®Google Scholar
• Herrmann IK, Wood MJA, Fuhrmann G. (2021). Extracellular vesicles as a next-generation drug delivery platform. Nat Nanotechnol 16:748–59.
   PubMed Web of Science ®Google Scholar
• Hu M, Zhang J, Yu Y, et al. (2020). Injectable liquid crystal formation system for reshaping tumor immunosuppressive microenvironment to boost antitumor immunity: postoperative chemoimmunotherapy. Small 16:e2004905.
   PubMed Web of Science ®Google Scholar
• Hu Z, Teng XL, Zhang T, et al. (2021). SENP3 senses oxidative stress to facilitate STING-dependent dendritic cell antitumor function. Mol Cell 81:940–52.e5.
   PubMed Web of Science ®Google Scholar
• Huang J, Xiao Z, An Y, et al. (2021). Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy. Biomaterials 269:120636.
   PubMed Web of Science ®Google Scholar
• Jhunjhunwala S, Hammer C, Delamarre L. (2021). Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion. Nat Rev Cancer 21:298–312.
   PubMed Web of Science ®Google Scholar
• Kuppner MC, Gastpar R, Gelwer S, et al. (2001). The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors. Eur J Immunol 31:1602–9.
   PubMed Web of Science ®Google Scholar
• Kwon ED, Drake CG, Scher HI, et al. (2014). Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol 15:700–12.
   PubMed Web of Science ®Google Scholar
• Li Q, Zhao Z, Qin X, et al. (2021). A checkpoint-regulatable immune niche created by injectable hydrogel for tumor therapy. Adv Funct Mater 31:2104630.
   Web of Science ®Google Scholar
• McHale AP, Callan JF, Nomikou N, et al. (2016). Sonodynamic therapy: concept, mechanism and application to cancer treatment. Adv Exp Med Biol 880:429–50.
   PubMed Web of Science ®Google Scholar
• Michaelis KA, Norgard MA, Zhu X, et al. (2019). The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nat Commun 10:4682.
   PubMed Web of Science ®Google Scholar
• Nezhadi S, Saadat E, Handali S, et al. (2021). Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities. J Drug Target 29:185–98.
   PubMed Web of Science ®Google Scholar
• Paardekooper LM, Vos W, van den Bogaart G. (2019). Oxygen in the tumor microenvironment: effects on DC function. Oncotarget 10:883–96.
   PubMedGoogle Scholar
• Pathria P, Louis TL, Varner JA. (2019). Targeting tumor-associated macrophages in cancer. Trends Immunol 40:310–27.
   PubMed Web of Science ®Google Scholar
• Patil SM, Sawant SS, Kunda NK. (2020). Exosomes as drug delivery systems: a brief overview and progress update. Eur J Pharm Biopharm 154:259–69.
   PubMed Web of Science ®Google Scholar
• Peng Y, Jia L, Wang S, et al. (2018). Sonodynamic therapy improves anti-tumor immune effect by increasing the infiltration of CD8+ T cells and altering tumor blood vessels in murine B16F10 melanoma xenograft. Oncol Rep 40:2163–70.
   PubMed Web of Science ®Google Scholar
• Pfirschke C, Siwicki M, Liao H-W, et al. (2017). Tumor microenvironment: no effector T cells without dendritic cells. Cancer Cell 31:614–5.
   PubMed Web of Science ®Google Scholar
• Poh AR, Ernst M. (2018). Targeting macrophages in cancer: from bench to bedside. Front Oncol 8:49.
   PubMed Web of Science ®Google Scholar
• Pullan JE, Confeld MI, Osborn JK, et al. (2019). Exosomes as drug carriers for cancer therapy. Mol Pharm 16:1789–98.
   PubMed Web of Science ®Google Scholar
• Runcie KD, Dallos MC. (2021). Prostate cancer immunotherapy—finally in from the cold? Curr Oncol Rep 23:88.
   PubMed Web of Science ®Google Scholar
• Schmid D, Park CG, Hartl CA, et al. (2017). T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity. Nat Commun 8:1747.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. (2021). Cancer statistics, 2021. CA Cancer J Clin 71:7–33.
   PubMed Web of Science ®Google Scholar
• Stultz J, Fong L. (2021). How to turn up the heat on the cold immune microenvironment of metastatic prostate cancer. Prostate Cancer Prostatic Dis 24:697–717.
   PubMed Web of Science ®Google Scholar
• Tormoen GW, Crittenden MR, Gough MJ. (2018). Role of the immunosuppressive microenvironment in immunotherapy. Adv Radiat Oncol 3:520–6.
   PubMedGoogle Scholar
• Wculek SK, Cueto FJ, Mujal AM, et al. (2020). Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol 20:7–24.
   PubMed Web of Science ®Google Scholar
• You B, Xu W, Zhang B. (2018). Engineering exosomes: a new direction for anticancer treatment. Am J Cancer Res 8:1332–42.
   PubMed Web of Science ®Google Scholar
• Zhao SG, Lehrer J, Chang SL, et al. (2019). The immune landscape of prostate cancer and nomination of PD-L2 as a potential therapeutic target. J Natl Cancer Inst 111:301–10.
   PubMedGoogle Scholar
• Zhou ZX, Sun L. (2015). Immune effects of R848: evidences that suggest an essential role of TLR7/8-induced, Myd88- and NF-κB-dependent signaling in the antiviral immunity of Japanese flounder (Paralichthys olivaceus). Dev Comp Immunol 49:113–20.
   PubMed Web of Science ®Google Scholar
• Zhu H, Fang X, Zhang D, et al. (2016). Membrane-bound heat shock proteins facilitate the uptake of dying cells and cross-presentation of cellular antigen. Apoptosis 21:96–109.
   PubMed Web of Science ®Google Scholar
• Zininga T, Ramatsui L, Shonhai A. (2018). Heat shock proteins as immunomodulants. Molecules 23:2846.
   PubMed Web of Science ®Google Scholar